Persistent anaemia after 4 weeks of iron and erythropoietin therapy requires further evaluation for other possible contributing factors, such as copper, ceruloplasmin or vitamin B12 deficiency, and appropriate treatment. This evidence concerns the gene EPO and anemia (phenotype).